Monitoring diabetes in patients with and without rheumatoid arthritis: a Medicare study

Table 2 Adjusted predicted probabilities and risk ratios for relationship between RA and diabetes testing (N = 256,331)*

	Unadjusted testing (%)	Adjusted predicted probability (%)	95% CI	Odds ratio	95% CI
Receipt of ≥2 A1c test
DM no RA	56.9	57.1	56.9 to 57.3	Referent
DM + RA	51.8	53.2	51.8 to 54.5	0.84	0.80 to 0.89
Receipt of ≥1 LDL test
DM no RA	76.7	76.7	76.5 to 76.8	Referent
DM + RA	75.5	77.8	76.8 to 78.8	1.08	1.01 to 1.16

*Models also adjusted for age, gender, race/ethnicity, Medicaid buy-in, RUCA code, HCC quartile, hospitalization in a three-year period, specific co-morbidities including diabetes complications, hyperlipidemia, chronic kidney disease, CVD, orthopedic surgeries, gait device, PCP visits and total providers.

ISSN: 1478-6362